These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32934464)

  • 1. Concomitant alcohol and sedative-hypnotic drug use among the elderly in Norway.
    Bye EK; Rossow I
    Nordisk Alkohol Nark; 2017 Feb; 34(1):18-27. PubMed ID: 32934464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative-hypnotic drug use among community-dwelling elderly in Taiwan.
    Tseng HY; Yu SH; Lee CY; Huang WH; Huang SL; Wu CS; Chiu YF; Hsiung CA
    Int Psychogeriatr; 2018 Jul; 30(7):957-965. PubMed ID: 29559028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of concomitant use of alcohol and sedative-hypnotic drugs in middle and older aged persons: a systematic review.
    Ilomäki J; Paljärvi T; Korhonen MJ; Enlund H; Alderman CP; Kauhanen J; Bell JS
    Ann Pharmacother; 2013 Feb; 47(2):257-68. PubMed ID: 23362039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sedative-hypnotic drug use and ageing.
    Morgan K
    Arch Gerontol Geriatr; 1983 Nov; 2(3):181-99. PubMed ID: 6360058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends, correlates, and disease patterns of sedative-hypnotic use among elderly persons in Taiwan.
    Kuo CL; Chien IC; Lin CH
    BMC Psychiatry; 2022 May; 22(1):316. PubMed ID: 35508990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedative-hypnotics are widely abused by drivers apprehended for driving under the influence of drugs.
    Kriikku P; Hurme H; Wilhelm L; Rintatalo J; Hurme J; Kramer J; Ojanperä I
    Ther Drug Monit; 2015 Jun; 37(3):339-46. PubMed ID: 25254415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and concentrations of sedative-hypnotic drugs in blood of drivers involved in road traffic crashes in the Padova region of Italy - not so easy to interpret.
    Favretto D; Visentin S; Jones AW
    Forensic Sci Int; 2022 Jan; 330():111097. PubMed ID: 34814082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey.
    Belleville G
    Can J Psychiatry; 2010 Sep; 55(9):558-67. PubMed ID: 20840803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents.
    Monane M; Glynn RJ; Avorn J
    Clin Pharmacol Ther; 1996 Jan; 59(1):83-92. PubMed ID: 8549038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and clinical course of sedative-hypnotic abuse and dependence in a large cohort.
    Schuckit MA; Smith TL; Kramer J; Danko G; Volpe FR
    Am J Drug Alcohol Abuse; 2002; 28(1):73-90. PubMed ID: 11853136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Impact of a Multimodel Intervention on Prescribing Patterns of Sedative-Hypnotics in a Behavioral Health System.
    Avdagic K; Geier M; Coralic Z; Finley P
    Prim Care Companion CNS Disord; 2018 May; 20(3):. PubMed ID: 29873949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription sleeping pills, insomnia, and suicidality in the National Comorbidity Survey Replication.
    Brower KJ; McCammon RJ; Wojnar M; Ilgen MA; Wojnar J; Valenstein M
    J Clin Psychiatry; 2011 Apr; 72(4):515-21. PubMed ID: 20868634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective.
    Tannenbaum C; Diaby V; Singh D; Perreault S; Luc M; Vasiliadis HM
    Drugs Aging; 2015 Apr; 32(4):305-14. PubMed ID: 25825121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between sedative-hypnotic medication use and incidence of cancer in Korean Nation Health Insurance Service data.
    Jung SJ; Lee J; Choi JW; Kim S; Shin A; Lee YJ
    Sleep Med; 2019 Aug; 60():159-164. PubMed ID: 31186214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of use of tranquilizers and sleeping pills across five surveys of the same population (1985-1991): the relationship with gender, age and use of other substances.
    Graham K; Vidal-Zeballos D
    Soc Sci Med; 1998 Feb; 46(3):381-95. PubMed ID: 9460819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypnotics, sleep, and mortality in elderly people.
    Rumble R; Morgan K
    J Am Geriatr Soc; 1992 Aug; 40(8):787-91. PubMed ID: 1634722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedative-hypnotic use by the elderly: effects on hospital length of stay and costs.
    Yuen EJ; Zisselman MH; Louis DZ; Rovner BW
    J Ment Health Adm; 1997; 24(1):90-7. PubMed ID: 9033160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedative-hypnotic drug use in Canada.
    Rawson NS; D'Arcy C
    Health Rep; 1991; 3(1):33-57. PubMed ID: 1863696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Following Nonfatal Opioid and Sedative/Hypnotic Drug Overdose.
    Goldman-Mellor S; Olfson M; Lidon-Moyano C; Schoenbaum M
    Am J Prev Med; 2020 Jul; 59(1):59-67. PubMed ID: 32389530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: A narrative review.
    Sweetman A; Putland S; Lack L; McEvoy RD; Adams R; Grunstein R; Stocks N; Kaambwa B; Van Ryswyk E; Gordon C; Vakulin A; Lovato N
    Sleep Med Rev; 2021 Apr; 56():101404. PubMed ID: 33370637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.